Next Article in Journal
Global Clinical Practice in Transitioning Protein Substitutes for Children with Phenylketonuria
Previous Article in Journal
Association Between the Consumption of Sugar-Sweetened Beverages and High-Caffeine Drinks and Self-Reported Mental Health Conditions Among Korean Adolescents
Previous Article in Special Issue
Dietary Intake of a Milk Sphingolipid-Rich MFGM/EV Concentrate Ameliorates Age-Related Metabolic Dysfunction
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control

by
Giovanni Sartore
1,
Giuseppe Zagotto
2 and
Eugenio Ragazzi
2,3,*
1
Department of Medicine—DIMED, University of Padova, 35128 Padova, Italy
2
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy
3
Studium Patavinum, University of Padova, 35122 Padova, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(16), 2653; https://doi.org/10.3390/nu17162653
Submission received: 29 July 2025 / Revised: 12 August 2025 / Accepted: 13 August 2025 / Published: 15 August 2025
(This article belongs to the Special Issue Diet and Nutrition: Metabolic Diseases---2nd Edition)

Abstract

Chlorophyll, the green pigment essential for photosynthesis, abundantly found in green vegetables and algae, has attracted growing scientific interest for its potential therapeutic effects, particularly in diabetes management. Recent research highlighted that chlorophyll and its derivatives may beneficially influence glucose metabolism and oxidative stress, key factors in diabetes. This review examines current knowledge on how chlorophyll compounds could aid diabetes control. Chlorophyll and its derivatives appear to support glucose regulation primarily through actions in the gastrointestinal tract. They modulate gut microbiota, improve glucose tolerance, reduce inflammation, and alleviate obesity-related markers. While chlorophyll itself does not directly inhibit digestive enzymes like α-glucosidase, its derivatives such as pheophorbide a, pheophytin a, and pyropheophytin a may slow carbohydrate digestion, acting as α-amylase and α-glucosidase inhibitors, reducing postprandial glucose spikes. Additionally, chlorophyll enhances resistant starch content, further controlling glucose absorption. Beyond digestion, chlorophyll derivatives show promise in inhibiting glycation processes, improving insulin sensitivity through nuclear receptor modulation, and lowering oxidative stress. However, some compounds pose risks due to photosensitizing effects and toxicity, warranting careful consideration. Chlorophyllin, a stable semi-synthetic derivative, also shows potential in improving glucose and lipid metabolism. Notably, pheophorbide a demonstrates insulin-mimetic activity by stimulating glucose uptake via glucose transporters, offering a novel therapeutic avenue. Overall, the antioxidant, anti-inflammatory, and insulin-mimicking properties of chlorophyll derivatives suggest a multifaceted approach to diabetes management. While promising, these findings require further clinical validation to establish effective therapeutic applications.
Keywords: chlorophyll; pheophorbide a; pheophytin a; chlorophyllin; diabetes; α-glucosidase inhibition chlorophyll; pheophorbide a; pheophytin a; chlorophyllin; diabetes; α-glucosidase inhibition

Share and Cite

MDPI and ACS Style

Sartore, G.; Zagotto, G.; Ragazzi, E. Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control. Nutrients 2025, 17, 2653. https://doi.org/10.3390/nu17162653

AMA Style

Sartore G, Zagotto G, Ragazzi E. Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control. Nutrients. 2025; 17(16):2653. https://doi.org/10.3390/nu17162653

Chicago/Turabian Style

Sartore, Giovanni, Giuseppe Zagotto, and Eugenio Ragazzi. 2025. "Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control" Nutrients 17, no. 16: 2653. https://doi.org/10.3390/nu17162653

APA Style

Sartore, G., Zagotto, G., & Ragazzi, E. (2025). Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control. Nutrients, 17(16), 2653. https://doi.org/10.3390/nu17162653

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop